Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Muscle- Invasive Bladder Cancer”

433 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 433 results

Large-scale testing (Phase 3)Study completedNCT07279792
What this trial is testing

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more
Ain Shams University 150
Not applicableNot Yet RecruitingNCT07285408
What this trial is testing

Sarcopenia and NMIBC Prognosis Study

Who this might be right for
Bladder Cancer Cell Transitional
General Hospital Sveti Duh 150
Testing effectiveness (Phase 2)Study completedNCT00191711
What this trial is testing

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 43
Large-scale testing (Phase 3)Active Not RecruitingNCT05943106
What this trial is testing

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Who this might be right for
Non-Muscle- Invasive Bladder Cancer
AstraZeneca 100
Not applicableStudy completedNCT04603612
What this trial is testing

The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.

Who this might be right for
Bladder Cancer
Mansoura University 254
Not applicableStudy completedNCT03664258
What this trial is testing

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)

Who this might be right for
Non-muscle-invasive Bladder Cancer
Cepheid 852
Testing effectiveness (Phase 2)Ended earlyNCT03719300
What this trial is testing

Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Anchiano Therapeutics Israel Ltd. 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793
What this trial is testing

Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more
First Affiliated Hospital of Wenzhou Medical University 106
Testing effectiveness (Phase 2)UnknownNCT05564897
What this trial is testing

Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Zhejiang Cancer Hospital 25
Not applicableLooking for participantsNCT06991868
What this trial is testing

Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

Who this might be right for
NMIBCMIBCUTUC
Peking University First Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT07019220
What this trial is testing

Chemoablation for Low-Grade Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Ekaterina Laukhtina 47
Testing effectiveness (Phase 2)Study completedNCT04593862
What this trial is testing

Bladder Cancer and ExeRcise Training During IntraVesical ThErapy

Who this might be right for
Bladder Cancer
University of Alberta 25
Testing effectiveness (Phase 2)Ended earlyNCT02010203
What this trial is testing

HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Who this might be right for
Bladder Cancer
Heat Biologics 104
Testing effectiveness (Phase 2)Looking for participantsNCT07122414
What this trial is testing

Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd 80
Testing effectiveness (Phase 2)Study completedNCT01697306
What this trial is testing

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
A.O.U. Città della Salute e della Scienza 120
Not applicableStudy completedNCT06020807
What this trial is testing

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

Who this might be right for
Non Muscle Invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial Carcinoma
Nucleix Ltd. 168
Not applicableLooking for participantsNCT07187063
What this trial is testing

Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Lahey Clinic 56
Not applicableUnknownNCT05704231
What this trial is testing

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder CancerSelf EfficacySmoking Behaviors+2 more
Bakirkoy Dr. Sadi Konuk Research and Training Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
ITM Oncologics GmbH 270
Large-scale testing (Phase 3)Study completedNCT00004154
What this trial is testing

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 111
Load More Results